ECGI Holdings Inc (ECGI)

[Potse]

Bozza LinkedIn, ECG website updates.....

Within the last several days, the Event Cardio Group website has been updated to include additions to the company's Advisory Board.....

http://www.eventcardiogroup.com/About_ECGI/Advisory_Board

Also within the last several days, Nicholas Bozza has updated his LinkedIn profile to reflect his involvement as Founder and Chief Product Officer of Event Cardio Group.

He also posted the following yesterday. I've placed a couple items of interest in bold. Bozza's use of the word "globally" in describing the launch of NowCardio in 2015 is a bit interesting to me since I was under the impression/belief the company was primarily/initially just focused on a United States (and perhaps Canada) launch in this upcoming year.....

Revolutionizing Patient Adherence (Cardiac Remote Monitoring & Breast Cancer Testing)

I'm excited to announce that Event Cardio Group Inc is a new medical device company focused on revolutionizing Patient Adherence in our diagnostic product line. I am the Founder and Medical CPO – Chief Product Officer and am sending you this message to let you know that we have plans to launch the NowCardio remote heart monitor sometime in 2015 globally. Moreover we are the exclusive Licensee of the BreastCare DTS™ to the US, Canada and Asia including China including certain rights to distribute globally. We want to keep you up to date with our progress whether you are a: 1) potential user 2) medical prescriber 3) part of a subscriber’s support team or 4) otherwise simply interested in participating in our company’s growth.

NowCardio, we believe will be the World’s First Leadless and Wireless Remote Heart Monitoring Device to conduct both a Loop Event Recorder and a Holter simultaneously while allowing Holter transferring of data for long durations (30-60 day intervals) to support physicians with better more meaningful data ‘When It Counts’. This will allow physicians to diagnose with greater accuracy and to provide more timely diagnosis and treatments of cardiac arrhythmias including atrial fibrillation (AF).

NEW in the field of Breast Cancer detection: Life Medicals BreastCare DTS™, a patented, non-invasive, FDA cleared adjunct to mammography and other established procedures for the detection of breast disease, including breast cancer. BreastCare DTS™ has the ability to compare temperatures in one area of the breast with others in the same breast and the other breast. DTS stands for “Differential Temperature Sensor”.

https://www.linkedin.com/pulse/article/20141105193105-129064721-revolutionizing-patient-adherence-cardiac-remote-monitoring-breast-cancer-testing?trk=prof-post